Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 98 | 105 | +7 |
| Shares | 8.57M | 13.3M | +4.78M (+55.8%) |
| Value | $49.5M | $24.4M | −$25.1M (−50.7%) |
New holders (26)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (19)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 76,523 | $442.3K |
| Wellington Management Group LLP | 65,633 | $379.4K |
| Millennium Management LLC | 30,222 | $174.7K |
| Two Sigma Investments, LP | 23,195 | $134.1K |
| Price T Rowe Associates Inc | 20,652 | $120.0K |
| Atom Investors LP | 17,747 | $102.6K |
| MetLife Investment Management | 15,167 | $87.7K |
| Wolverine Trading, LLC | 12,161 | $71.3K |
| Pathstone Holdings, LLC | 10,266 | $59.3K |
| Russell Investments Group, Ltd. | 1,733 | $10.0K |
| nVerses Capital, LLC | 1,000 | $5.78K |
| Valley National Advisers Inc | 636 | $3.00K |
| City State Bank | 183 | $1.06K |
| Capital Performance Advisors LLP | 83 | $480 |
| AdvisorNet Financial, Inc | 58 | $335 |
| GWM Advisors LLC | 58 | $335 |
| Clear Point Advisors Inc. | 31 | $179 |
| GAMMA Investing LLC | 24 | $139 |
| Tortoise Investment Management, LLC | 20 | $116 |